![](https://endpts.com/wp-content/uploads/2023/07/Biotech-merger-acquisition-consolidation-shutterstock-feature.jpg)
Illustration: Shutterstock
Biotech’s optimism is returning amid signs of a better second half and a brighter 2024
Odysseus eventually made it to shore, as BridgeBio CEO Neil Kumar reminded the industry last Friday in a nod to Homer’s classic tale. And …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.